Youxiang Chen

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2

Ju Huang, Youxiang Chen, Bo Zhang · Gastric Cancer · 2019 · 60 citations · Full text

Tumor Biology, Medicine, Pathology +9

MicroRNA-7 suppresses human colon cancer invasion and proliferation by targeting the expression of focal adhesion kinase

Chunyan Zeng, YI-SHAN ZHAN, Jun Huang et al. · Molecular Medicine Reports · 2015 · 35 citations · Full text

SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway

Bixia Liu, Yang Xie, Jiayu Zhang et al. · International Immunopharmacology · 2024 · 30 citations

Tumor Biology, Colorectal Cancer Invasion, Medicine +9